A cerebrospinal fluid test may be able to predict who is likely to develop Parkinson’s disease years before the first…
Parkinsons
Teva and Viatris win US appeal in Parkinson’s disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz]
Here is a summary of health news briefs. Teva and Viatris win US appeal in Parkinson’s disease drug patent fight…